|
TNRC6B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.154199999997E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.562370E-02 |
| Normal-vs-Stage2 |
3.037300E-03 |
| Normal-vs-Stage3 |
1.12119999950977E-07 |
| Normal-vs-Stage4 |
1.84509999945348E-07 |
| Stage1-vs-Stage2 |
2.327800E-01 |
| Stage1-vs-Stage3 |
3.764600E-04 |
| Stage1-vs-Stage4 |
6.769900E-04 |
| Stage2-vs-Stage3 |
1.705390E-01 |
| Stage2-vs-Stage4 |
1.291020E-01 |
| Stage3-vs-Stage4 |
7.516200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.53470000000234E-05 |
| Normal-vs-AfricanAmerican |
1.015850E-04 |
| Normal-vs-Asian |
4.665600E-01 |
| Caucasian-vs-AfricanAmerican |
2.376800E-01 |
| Caucasian-vs-Asian |
4.098300E-02 |
| AfricanAmerican-vs-Asian |
2.063900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.65879999997265E-06 |
| Normal-vs-Female |
8.786100E-04 |
| Male-vs-Female |
1.616990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.159800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.203000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.64110000039553E-07 |
| Normal-vs-Age(81-100Yrs) |
8.061100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.960000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.216600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.007800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.741400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.180500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.537600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.632000E-01 |
| Normal-vs-Grade 2 |
7.758500E-03 |
| Normal-vs-Grade 3 |
4.91110000000461E-06 |
| Normal-vs-Grade 4 |
3.28510000313642E-08 |
| Grade 1-vs-Grade 2 |
7.395800E-02 |
| Grade 1-vs-Grade 3 |
6.424700E-03 |
| Grade 1-vs-Grade 4 |
3.152900E-04 |
| Grade 2-vs-Grade 3 |
2.601600E-02 |
| Grade 2-vs-Grade 4 |
6.398900E-04 |
| Grade 3-vs-Grade 4 |
5.435500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.388400E-02 |
| Normal-vs-ccB subtype |
1.015730E-04 |
| ccA subtype-vs-ccB subtype |
1.926170E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.225900E-04 |
| Normal-vs-N1 |
1.861550E-03 |
| N0-vs-N1 |
2.834600E-01 |
|
|
